Indaptus Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell INDP and other ETFs, options, and stocks.About INDP
Indaptus Therapeutics, Inc. is a pre-clinical biotechnology company. It engages in the development of a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy.
CEOJeffrey A. Meckler
CEOJeffrey A. Meckler
Employees7
Employees7
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded
Founded
Employees7
Employees7
INDP Key Statistics
Market cap3.65M
Market cap3.65M
Price-Earnings ratio-0.09
Price-Earnings ratio-0.09
Dividend yield—
Dividend yield—
Average volume22.85K
Average volume22.85K
High today$4.77
High today$4.77
Low today$3.30
Low today$3.30
Open price$4.00
Open price$4.00
Volume132.48K
Volume132.48K
52 Week high$58.24
52 Week high$58.24
52 Week low$3.21
52 Week low$3.21
INDP News
TipRanks 2d
Indaptus Therapeutics Reports Mixed Results in Clinical TrialElevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...
People also own
Based on the portfolios of people who own INDP. This list is generated using Robinhood data, and it’s not a recommendation.